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Complex interventionsehow should systematic reviews of their impact
differ from reviews of simple or complicated interventions?Although clinical research often tries to reduce and sim-
plify reality to be able to study its essential elements, it is
increasingly recognized that in practice many health care
interventions are complex. Therefore, this month’s issue
of the Journal of Clinical Epidemiology presents a timely
series on considering complexity in systematic reviews of
interventions. Anderson et al. provide a brief introduction
to complexity thinking and how this relates to simple and
complicated interventions. They provide an overview of
the seven original articles included in this series. The first
article, by Petticrew et al., presents a pragmatic approach
to considering complexity in systematic reviews. Particular
attention is paid to the importance of clarifying the research
question, identifying sources of complexity, and mapping
dimensions of complexity onto appropriate sources of evi-
dence. In a second article Squires and colleagues speak to
the importance of clarifying the review question about the
effects of complex interventions. Guidance on how to for-
mulate review questions for complex interventions is dis-
cussed. Subsequently Anderson and colleagues provide an
overview of the various types of evidence that could be
incorporated into systematic reviews that investigate
complex interventions. They offer guidance on how to select
appropriate methods and sources of information. The next
article, by Petticrew et al., delves into how various meta-
analytical approaches could be used to examine complexity.
In particular, they focus on qualitative and mixed-method
approaches that are becoming more popular when synthesiz-
ing complex interventions. The fifth article, by Pigott and
Shepperd, identifies potential sources of heterogeneity in
systematic reviews of complex interventions. Guidance on
how to code and examine each of these sources of heteroge-
neity is presented. In the sixth article, Burford and col-
leagues explore considerations of the applicability of
systematic reviews of complex interventions. They offer
existing tools and specific data sources that could assist users
in applying the findings of reviews that take into account
complexity. Finally, Noyes and associates, outlines research
and development agenda for the future of considering
complexity in systematic reviews. Along with this series,
there are two commentaries. In a commentary, Wong asks
the important question of ‘Is complexity just too complex?’
given the large number of complex factors that may come
into play and the lack of agreement among researchers as0895-4356/$ - see front matter  2013 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.jclinepi.2013.09.003to how complexity is conceptualized. He concludes by
stating that we need to make a conscious effort to understand
our own assumptions e regardless of whether the interven-
tion is complex or not. If we can do this, then we can begin
to understand the complexity in the interventions that we
seek to synthesize. Tharyan, in the second commentary, uses
the example of directly observed treatment short-course
(DOTS) for tuberculosis as an example of a complex inter-
vention. He discusses some of the issues of complexity
that have plagued this program and how this series might
begin to address some of these methodological issues.
Another topic that is extenslively covered in this issue is
diagnosis and clinical prediction. Diagnostic test meta-
analyses methods have evolved (for example, one should
not simply pool each of sensitivity and specificity from dif-
ferent studies since separate pooling of sensitivity and spec-
ificity estimates fails to account for the trade-off between
sensitivity and specificity, which may lead to underesti-
mates of test accuracy) [1]. Meta-analyses of diagnostic
tests aims to compute and compare estimates of the ex-
pected diagnostic accuracy of a test and investigate the var-
iability of results between studies. A choice needs to be
made as to which summary statistics are to be computed.
In Cochrane reviews, advanced methods are provided to es-
timate expected values of sensitivity and specificity for the
test at a common threshold (referred to as the average op-
erating point), or to estimate a Summary ROC Curve [2].
Ochodo et al. found that although the above advanced
methods for meta-analysis are recommended by The Co-
chrane Collaboration, authors using traditional methods in-
dicated that they believed that the methods they used are
currently recommended. The authors recommend ways by
which to disseminate the benefits of the advanced methods
of meta-analysis to the relevant audiences.
Steurer and colleagues aimed to illustrate how diagnos-
tic experts’ case-specific tacit knowledge about diagnostic
probabilities could be garnered in the form of ‘Diagnostic
Probability Functions.’ These were successfully collected
electronically for 100 clinical scenarios of patients with
suspected myocardial infarction from a panel of seasoned
expert clinician. The experts’ probabilities in any given
case had a surprisingly large degree of variability. The
authors argue that this approach with further validation be
used to develop practice-guiding diagnostic expert systems.
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prediction rule. As he states, for the validation in an exter-
nal data set, two basic principles are usually advocated and
used in practice: calibration and discrimination. Calibration
aims to check whether the event probabilities according to
the prediction rule coincide with the event rates that we can
observe in an external validation data set. Discrimination
refers to the ability of the prognostic model to separate sub-
jects with an event from subjects without an event. This
paper reviews calibration and looks at the contributions of
bias and residual variation. If the rule is based on a linear
logistic model, it is often assumed that an overestimation
of all coefficients results in a calibration slope less than
1 and an underestimation in a slope larger than 1. Vach
investigated the relation of the bias and the residual varia-
tion of clinical prediction rules with the typical behavior of
calibration plots and calibration slopes, using some artifi-
cial examples. He found that calibration is not only sensi-
tive to the bias of the clinical prediction rule, but also to
the residual variation. In some circumstances, the effects
may cancel out, resulting in a misleading perfect calibra-
tion. He concludes that poor calibration is a clear indication
of limited usefulness of a clinical prediction rule. However,
he cautions that a perfect calibration should be interpreted
with care as this may happen even for a biased prediction
rule.
The propensity score method is increasingly used to
assess treatment effects in nonrandomized trials. In an orig-
inal article, Kuss proposes the z-difference to assess covar-
iate balance in matched propensity score analyses. He
maintains that the z-difference improves on two defi-
ciencies of the standardized difference, the commonly used
measure of covariate balance in matched propensity score
analyses. Firstly, the distribution of the z-difference does
not depend on sample size and secondly the z-difference
allows comparing balance of baseline covariates on differ-
ent scales (continuous, binary, ordinal, or nominal
covariates).
Unverzagt and co-workers sought to assess whether the
reported trial characteristics are associated with treatment
effects on all-cause mortality within critical care medicine.They found that single-center trials in critical care medicine
tend to provide larger treatment effect estimates than mul-
ticenter trials. However, larger multicenter RCTs are much
more difficult to conduct due to the difficulty in comparing
of baseline conditions as well as financing and sponsoring.
The authors conclude that results from single-center trials
should be cautiously used for decision-making. In
addition, they advise that RCTs investigating expensive
therapeutic concepts should be financed and supervised
by national and international scientific societies and not
solely by pharmaceutical companies.
Richardson and colleagues interviewed over two and
a half thousand individuals to estimate the agreement
between interview-ascertained medication use and phar-
macy records among the population aged older than
50 years in order to identify patient-level predictors of dis-
cordance. They found that ascertaining medication use via
patient interview was a valid method for most medication
classes and also captures non-prescription and supplement
use. The authors conclude that studies planning to ascertain
medication use should carefully consider questionnaire
design and interviewer training to better record underre-
ported classes including those with social stigma.
Finally in this month’s edition, we are publishing two
papers in the ‘effective writing and publishing of scientific
papers’ series. The first paper, part VII, provides guidance
on tables and figures while the second paper, part VIII, pro-
vides useful guidance on referencing systems.
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